Gradient Investments’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-25
Closed -$85 1779
2023
Q1
$85 Hold
25
﹤0.01% 1447
2022
Q4
$90 Hold
25
﹤0.01% 1433
2022
Q3
$0 Hold
25
﹤0.01% 1351
2022
Q2
$0 Buy
+25
New +$180 ﹤0.01% 1226

Other funds holding SRTA

Gradient Investments's SRTA Position: Q2 2023 in Review

Gradient Investments sold out of Strata Critical Medical Inc (SRTA) in Q2 2023, closing a stake of 25 shares — an estimated $85 sold.

Gradient Investments first reported a position in SRTA in Q2 2022 and held it in 4 quarters. The position peaked at $90 in Q4 2022. 93 funds tracked by Wall St. Rank hold SRTA as of Q2 2023.

  • Gradient Investments reported no remaining Strata Critical Medical Inc position as of Q2 2023 after selling out during the quarter.
  • Gradient Investments sold 25 Strata Critical Medical Inc shares in Q2 2023, an estimated $85.
  • Gradient Investments first reported a position in Strata Critical Medical Inc in Q2 2022 and held it in 4 quarters.
  • Gradient Investments's Strata Critical Medical Inc position peaked at $90 in Q4 2022.
  • 93 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2023.

Based on Gradient Investments's 13F filing for Q2 2023, filed 11 Jul 2023.